TY - JOUR
T1 - The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer
AU - Wang, Jianhua
AU - Shiozawa, Yusuke
AU - Wang, Jincheng
AU - Wang, Yu
AU - Jung, Younghun
AU - Pienta, Kenneth J.
AU - Mehra, Rohit
AU - Loberg, Robert
AU - Taichman, Russell S.
PY - 2008/2/15
Y1 - 2008/2/15
N2 - Several reports have recently documented that CXCR7/RDC1 functions as a chemokine receptor for SDF-1/CXCL12, which regulates a spectrum of normal and pathological processes. In this study, the role of CXCR7/RDC1 in prostate cancer (PCa) was explored. Staining of high density tissue microarrays demonstrates that the levels of CXCR7/RDC1 expression increase as the tumors become more aggressive. In vitro and in vivo studies with PCa cell lines suggest that alterations in CXCR7/RDC1 expression are associated with enhanced adhesive and invasive activities in addition to a survival advantage. In addition, it was observed that CXCR7/RDC1 levels are regulated by CXCR4. Among the potential downstream targets of CXCR7/RDC1 are CD44 and cadherin-11, which are likely to contribute to the invasiveness of PCa cells. CXCR7/RDC1 also regulates the expression of the proangiogenic factors interleukin-8 or vascular endothelial growth factor, which are likely to participate in the regulation of tumor angiogenesis. Finally, we found that signaling by CXCR7/RDC1 activates AKT pathways. Together, these data demonstrate a role for CXCR7/RDC1 in PCa metastasis and progression and suggest potential targets for therapeutic intervention.
AB - Several reports have recently documented that CXCR7/RDC1 functions as a chemokine receptor for SDF-1/CXCL12, which regulates a spectrum of normal and pathological processes. In this study, the role of CXCR7/RDC1 in prostate cancer (PCa) was explored. Staining of high density tissue microarrays demonstrates that the levels of CXCR7/RDC1 expression increase as the tumors become more aggressive. In vitro and in vivo studies with PCa cell lines suggest that alterations in CXCR7/RDC1 expression are associated with enhanced adhesive and invasive activities in addition to a survival advantage. In addition, it was observed that CXCR7/RDC1 levels are regulated by CXCR4. Among the potential downstream targets of CXCR7/RDC1 are CD44 and cadherin-11, which are likely to contribute to the invasiveness of PCa cells. CXCR7/RDC1 also regulates the expression of the proangiogenic factors interleukin-8 or vascular endothelial growth factor, which are likely to participate in the regulation of tumor angiogenesis. Finally, we found that signaling by CXCR7/RDC1 activates AKT pathways. Together, these data demonstrate a role for CXCR7/RDC1 in PCa metastasis and progression and suggest potential targets for therapeutic intervention.
UR - http://www.scopus.com/inward/record.url?scp=42949133032&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=42949133032&partnerID=8YFLogxK
U2 - 10.1074/jbc.M707465200
DO - 10.1074/jbc.M707465200
M3 - Article
C2 - 18057003
AN - SCOPUS:42949133032
SN - 0021-9258
VL - 283
SP - 4283
EP - 4294
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 7
ER -